BenevolentAI Results Presentation Deck

Our flexible business model unlocks multiple routes to value creation Al-Discovery Tools Knowledge Graph Precision Medicine 00 W Target Identification Molecular Design •To OWNED PIPELINE Platform-generated assets ● • In-house development LICENSING ● Platform-generated assets • Out-licensed at IND, end Phase I or end II PLATFORM COLLABORATIONS ● Economic Benefits • Platform Validation • Data generated enriches the Benevolent Platform™ NON-COMMERCIAL COLLABORATIONS ESG • Platform Validation • Data generated enriches the Benevolent Platform™ ● BenevolentAl Proprietary Benevolent 8

View entire presentation